Associate Professor, Pulmonary, Critical Care and Sleep Medicine Division, Icahn School of Medicine
Adam Morgenthau, MD, received his medical degree from the Sackler School of Medicine in Tel Aviv, Israel and went on to complete his residency at North Shore University Hospital in New York. He attended his Pulmonary and Critical Care Fellowship at the John Hopkins University School of Medicine. His clinical interests are focused on sarcoidosis. Dr. Morgenthau is currently the Director of Mount Sinai’s Sarcoidosis Clinic and the recently renamed, Alvin S. Teirstein Sarcoidosis Support Group. He currently cares for a cohort of approximately 350 patients with sarcoidosis. Dr. Morgenthau is a member of World Association of Granulomatous Diseases and the Scientific Advisory Board for the Foundation for Sarcoidosis Research. Dr. Morgenthau’s research, like his clinical interests are in Sarcoidosis. He is currently leading or involved in the following projects: Assessing the safety and tolerability of an antibody directed against macrophage colony-stimulating factor; a prospective study evaluating forced oscillation testing in patients with sarcoidosis; and a descriptive study characterizing the differences in clinical features among Hispanic, Caucasian and African American sarcoidosis patients.